FORA - NASDAQ
Forian Inc.
$2.17
+0.0000%Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies. In addition, the company offers security monitoring and web marketing services. The company is headquartered in Newtown, Pennsylvania.
At a Glance
Live Snapshotfora
Total Current Assets
Last Annual Value
42.56M
3-Year CAGR
16%
5-Year CAGR
28%
10-Year CAGR
73%
Forian Inc. Competitors Analysis of Total Current Assets
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Forian Inc. NASDAQ:FORA | 42.56M | -10.0% | 3.4% | N/A | |
 Nutriband Inc. NASDAQ:NTRB | 4.79M | 67.4% | -2.6% | 62.3% | |
 Gain Therapeutics, Inc. NASDAQ:GANX | 22.24M | 7.7% | -10.0% | N/A | |
 Clene Inc. NASDAQ:CLNN | 8.98M | -38.6% | -30.3% | N/A | |
 Immix Biopharma, Inc. NASDAQ:IMMX | 101.24M | 72.3% | 41.0% | N/A | |
 Prelude Therapeutics Incorporated NASDAQ:PRLD | 105.69M | -23.4% | -18.6% | N/A | |
 Great Elm Group, Inc. NASDAQ:GEG | 137.90M | 3.8% | 9.3% | 5.5% | |
 Pulmonx Corporation NASDAQ:LUNG | 101.68M | -12.2% | -13.3% | N/A | |
 TScan Therapeutics, Inc. NASDAQ:TCRX | 152.41M | -7.8% | -1.7% | N/A | |
 OneMedNet Corporation NASDAQ:ONMD | 3.62M | 115.0% | 34.1% | N/A | |
 American Well Corporation NYSE:AMWL | 246.68M | -18.1% | -21.5% | N/A |
Forian Inc. Fair Value Envelope
Related Guides
Continue your FORA research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.